Lee Enterprises, Incorporated
Lee Enterprises Reports Results for Third Fiscal Quarter
Published in Health Business Week, August 14th, 2009
Lee Enterprises, Incorporated (NYSE:LEE), reduced cash operating expenses, excluding unusual items(1), 22.0 percent in its third fiscal quarter ended June 28, 2009, as operating revenue declined 20.5 percent. Excluding non-cash impairment charges and other unusual items, diluted earnings per common share were 12 cents, compared with 30 cents a year ago. Free cash flow(2) totaled $22.1 million, compared with $34.2 million in 2008.
Including non-cash impairment charges, Lee recorded a loss per diluted common share of 55 cents for the quarter, compared with earnings of 6 cents per share a year ago.
"We are continuing to position Lee so it will emerge...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2009-08-14)
More Articles from Health Business Week
- 1-800-FLOWERS.COM, Inc.
Celebrate National Friendship Day With 1-800-FLOWERS.COM - 3M
3M Introduces Highly Conformable, Non-Woven Conductive Tapes - AARP
Consumer Cellular Offers AARP Members Additional Value - Abbott
Abbott and Medtronic Reach Agreement on Global Patent Disputes - Abbott
Abbott Testifies Before U.S. Congress on Role of Private Sector in Advancing Science Education - Acceleron Pharma, Inc.
Acceleron and Celgene Initiate Phase 2 Study of ACE-011 to Treat Chemotherapy-Induced Anemia - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
